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Preface to the special issue of Food and Chemical Toxicology on the
outcomes of the MARLON project on veterinary epidemiology of potential
health impacts of genetically modified feeds in livestock
This special issue is a collection of articles dedicated to the impact of
genetically modified (GM) animal feeds on the health of livestock. It fea-
tures the outcomes of the research project titled “Monitoring of Animals
for Feed-related Risks in the Long Term (MARLON)”. MARLON was a
three-year research project funded by the European Union's (EU) Seventh
Framework Program for research and technology development (MARLON,
2015). It focused on monitoring livestock in commercial production sce-
narios for potential health impacts associated with feeds containing GM
ingredients. There has been a rapid rate of adoption of GM feed in-
gredients especially GM-soybean, maize, oilseed rape and cottonseed in
non-EU countries, since their commercial large-scale introduction in the
mid-90s (James, 2017). They are now common ingredients in livestock
feed. In addition to addressing GM feeds, the methodology and insights
gained from the project can be broadly applied to the surveillance of
health effects of livestock feeds and hazards in general.
MARLON operated at the interface of science, legislation, and policy. It
brought together scientists from 11 European institutions with com-
plementary expertise including veterinary health and epidemiology, live-
stock production, biosafety of GM crops, and food and feed safety.
MARLON's activities included stakeholder consultations, a training course,
and a final conference. The main outcomes of MARLON were new
knowledge, guidelines, and methodologies for monitoring GM feed in-
gredient-related health impacts for key stakeholders including European
regulators. MARLON's progressive approach relates to the possibility that
monitoring of GM feeds and foods may become necessary because they are
regulated and can only be marketed after regulatory approval. In fact, EU
legislation on GM foods and feeds has a provision that a post-market
monitoring may be required based on the outcome of the pre-market risk
assessment (EU, 2003). Thus, a key outcome of MARLON was providing
European policy makers with pertinent new knowledge on several safety
topics regarding GM crops which added to the outcomes from other EU
projects including the GMSAFOOD, GRACE, and G-TwYST projects and
the French government-funded GMO90 + project that focussed on in vivo
and in vitro biomarkers, methods for safety testing of GM crops, and col-
lation of the existing evidence on the potential health, environmental, and
economic impacts of GM crops.
When the MARLON project began, there were a few challenges to ad-
dress. For example, a requirement for case-specific monitoring to verify po-
tential risks identified or assumptions made during the pre-market safety
assessment was only necessary for foods derived from GM oilseed crops
with a modified fatty acid composition, which might have potential to
impact human nutrition and health. In addition, there was a requirement
for general, passive surveillance of animal health impacts as part of the
general surveillance carried out for all GM crops that had received approval
for “environmental release” (e.g., field cultivation, import and processing of
seeds and other viable GM crop products) (EU, 2001). Therefore, MARLON
activities had to be anticipatory because it was not possible to rely on past
case-specific monitoring experience. This was especially challenging be-
cause negative health effects due to approved GM products were not known
to exist. Another challenge was that the approach to developing monitoring
methods should be universally applicable because it was not possible to
foresee for which combination of GM feed, livestock species, and health
parameters monitoring could be required. Additionally, it was necessary to
use data from existing animal health surveillance activities, which were
either generic or focused on the impact of non-feed-related animal health.
This special issue addresses the following questions:
• Are there known health impacts related to GM-crop-derived live-
stock feeds? (De Vos and Swanenburg, 2018)?
• Would it be possible to measure the exposure of animals to specific
GM feed ingredients? (Nadal et al., 2018)?
• Can health indicators be specified by regulators for the monitoring of
livestock for possible health effects of GM feeds? (De Santis et al., 2018)?
• How are different feed and livestock production chains organized
and characterised (e.g., husbandry practices, regulations, trace-
ability, and health checks)? (Kleter et al., 2018)?
• Is it possible to design monitoring programs to exploit data from
existing surveillance for the detection of unusual trends in animal
health parameters such as those collated in IPAFEED, and relate this
to the consumption of GM feeds? (Vince et al., 2018)?
De Vos and Swanenburg, in their review of the literature, addressed
whether there are known health impacts related to GM-crop-derived live-
stock feeds (De Vos and Swanenburg, 2018). They focussed on controlled
livestock feeding studies to collate state-of-the-art knowledge on health
parameter (e.g., serum chemistry, pathology, etc.) perturbations associated
with the feeding of GM ingredients. From this, it was concluded that feeds
formulated to include first-generation GM crops were at least as safe as
feeds produced from non-GM feed ingredients. They state that it is too early
to reach a conclusion regarding second-generation GM crops (with im-
proved outputs traits) because these have only recently become available. A
systematic annotation of the health parameters measured in livestock
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feeding studies is provided in the IPAFEED database (IPAFEED, 2015; Vince
et al., 2018). Regulators can now use information from IPAFEED to assess
the design of monitoring schemes based on previously reported health
parameters.
The review by Nadal and co-workers (Nadal et al., 2018) focussed
on whether it would be possible to measure the exposure of animals to
specific GM feed ingredients with the notion that it might link exposure
to ingredients with adverse health effects in an individual or cohort of
animals. They also addressed whether ingredients could be traced and
detected throughout the feed and livestock production chains, and
whether there are markers for exposure in livestock animals (e.g., via
uptake of GM material from feed into tissues, fluids, and excreta). The
review concludes that although it is possible to measure the presence of
specific ingredients in feeds based on GM-crop-related proteins or DNA,
there are no markers for animal exposure. Therefore, traceability
measures have not yet traced and quantified an animal's exposure to a
specific GM feed ingredient.
De Santis and co-workers addressed whether health indicators can
be specified by regulators for the monitoring of livestock for possible
health effects of GM feeds in their review (De Santis et al., 2018). They
explored four scenarios: 1) potential allergic reactions induced by GM
feeds as compared to non-GM feeds in livestock animals; 2) horizontal
gene transfer from consumed GM crops to intestinal microorganisms
and the host animal; 3) reduced incidence of mycotoxins in GM feeds;
and 4) nutritionally altered GM crops. The authors concluded that there
were no adverse effects to GM feeding in the literature for these sce-
narios. There is evidence, however, of beneficial effects related to a
reduction of the mycotoxin fumonisin in insect-resistant GM crop
varieties and through nutritional enhancement of crops.
The Kleter and co-workers’ (Kleter et al., 2018) review approached
the organization and characterization of different feed and livestock
production chains (e.g., husbandry practices, regulations, traceability,
and health checks) with the aim to determine how the movement of
feeds and animals through the production chain is recorded and how
this could be used for monitoring of animal health effects. The authors
concluded that for livestock, traceability at herd or individual levels are
possible depending on the livestock species. Although the existing an-
imal traceability systems are designed for infectious disease reporting
or animal identification, it is not possible to trace GM ingredients (even
if it is labelled correctly) back to the farms of origin or to verify the
distribution and inclusion level in the feeds.
The last review by Vince and co-workers addresses designing
monitoring programs to exploit data from existing surveillance for the
detection of unusual trends in animal health parameters, such as those
collated in IPAFEED, and relate this to the consumption of GM feeds.
The review reveals a broad methodology to assist the monitoring of GM
feed-related health effects (Vince et al., 2018). This was a key challenge
for MARLON because there were no recorded GM feed-related health
effects and no methods for quantifying prior exposure of the animals to
GM feed. The authors reviewed various types of existing veterinary
surveillance, which aim at providing evidence for freedom from specific
diseases, early detection of outbreaks, and monitoring of endemic dis-
eases including syndromic surveillance (e.g., non-specific health para-
meters), risk-based surveillance, collection-point-based surveillance,
checkpoint surveillance, sentinel herd surveillance and representative
surveys. In addition, they reported on a probabilistic approach towards
syndromic surveillance that estimates the likelihood that an effect will
be detected above background variability through existing reporting
systems. Importantly, this approach considers the production chain,
from farmer via veterinarian and clinical laboratory, to post-mortem
abattoir inspection. The authors concluded that observed effects or
deviating trends would need follow-up with confirmatory research
under controlled conditions and suggested that managers should con-
sider cost-effectiveness compared with alternative options when setting
up a surveillance scheme.
In summary, the reviews in this issue provide comprehensive
overviews of published controlled feeding livestock studies with GM
crops checking for health impacts beyond solely performance, the
possibilities to detect GM feed ingredients and the animals’ exposure to
them, the possibility to employ health indicators for four hypothetical
scenarios including allergenicity, horizontal gene transfer, changed
mycotoxin levels, and nutritional improvement, the organization of
feed and livestock production chains in Europe, and the possibilities for
applying veterinary epidemiology to surveillance of possible GM feed-
related health impacts. The generic, statistical approach developed
within MARLON will assist in the design of monitoring programs based
on syndromic surveillance for GM and non-GM feeds which would then
rely on existing data of health syndromes commonly measured in li-
vestock production. This also concurs with recent trends in syndromic
surveillance, mining of big data, and domestic animal toxicology.
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